Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,650,000
-
Number of holders
-
345
-
Total 13F shares, excl. options
-
131,997,507
-
Shares change
-
+3,454,319
-
Total reported value, excl. options
-
$5,220,452,246
-
Value change
-
+$129,179,246
-
Put/Call ratio
-
43%
-
Number of buys
-
176
-
Number of sells
-
172
-
Price
-
$39.54
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q3 2022
As of 30 Sep 2022 HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) had 419 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 131,997,507 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Artisan Partners Limited Partnership, Invesco Ltd., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, JPMORGAN CHASE & CO, MACQUARIE GROUP LTD, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 419 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.